Yumi Tsuchiya

Featured in: Favicon

Articles

Phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group study of ustekinumab in Japanese patients with active polymyositis and dermatomyositis who have not adequately responded to one or more standard-of-care treatments

Aug 1, 2023 | rmdopen.bmj.com | Kimito Kawahata |Tomonori Ishii |Takahisa Gono |Yumi Tsuchiya

DiscussionThe present study assessed the efficacy of UST in Japanese participants with active PM/DM despite treatment with one or more standard-of-care treatments.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →